At the forefront of therapies for rare and orphan diseases
science & technology
news & events
welcome from chairman & CEO
amicus belief statement
Epidermolysis Bullosa (EB)
protein misfolding & disease
pharmacological chaperone technology
posters, abstracts & publications
patient advocacy at amicus
general disease information
patient advisory boards
ongoing clinical studies
senior management team
board of directors
events and presentations
is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases.
Amicus Therapeutics to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Amicus Therapeutics Provides Full-Year 2016 Strategic Outlook and Financial Guidance
Amicus Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference and 3rd Annual Dermatology Summit
Amicus Therapeutics CEO: Driving science to a cure
John Crowley, Amicus Therapeutics chairman and CEO, discusses its Fabry pill development and next generation therapy for Pompe disease, with CNBC's Jim Cramer.
Click Here to Read the Article
Copyright © 2016 Amicus Therapeutics, Inc. All rights reserved.